Viewing Study NCT04882033


Ignite Creation Date: 2025-12-25 @ 2:43 AM
Ignite Modification Date: 2025-12-31 @ 1:17 AM
Study NCT ID: NCT04882033
Status: UNKNOWN
Last Update Posted: 2021-05-11
First Post: 2021-05-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung Cancer
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module